Login
Aurora Cannabis NYSE: ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products.
| Name | Aurora Cannabis |
| Ticker | ACB |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
|
Price
52W Low/High |
7.79
3.83 / 18.92 |
| Momentum | Sharp Down |
| Market cap | 1.0 B |
| 1Y Total Return |
-2.90%
Weak |
| 1Y Volatility |
141.96%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aurora Cannabis Inc. produces and distributes medical cannabis products.
Details
| Ticker | ACB |
| Name | Aurora Cannabis |
| ISIN | |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 4/15/21
| Close Price | 7.79 |
| 52W Low/High | 3.83 / 18.92 |
| Market cap | 1.0 B |
| 1Y Total Return |
-2.90%
Weak |
| 1Y Volatility |
141.96%
High Risk |
| Beta | 2.52 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -857.6% |
| Cash from Op. / Cur. Liabilities | -1.88 |
| Diluted Earnings / Share | -17.81 |
| ROE | - |
| ROIC | -72.5% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 5.0 |
| Cur.Liabilities / Tot.Liabilities | 0.2 |
| Financial Leverage | 0.22 |
| in Mils USD |
rolling-year up to December
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
222
|
222
|
88
|
-
|
|
| Gross Profit |
-
|
122
|
51
|
-
|
|
| R&D |
14
|
17
|
5
|
-
|
|
| EBITDA |
-1,827
|
-1,009
|
-5
|
-
|
|
| Operating Income |
-301
|
-250
|
-200
|
-
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
-17.81
|
-12.20
|
0.00
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
2,220
|
3,566
|
3,612
|
-
|
|
| Cash, Eq & Invt ShortTerm |
347
|
182
|
154
|
-
|
|
| Total Current Assets |
582
|
481
|
292
|
-
|
|
| Total Non-Current Assets |
1,637
|
3,086
|
3,320
|
-
|
|
| Intangibles |
1,032
|
2,224
|
2,774
|
-
|
|
| Total Liabilities |
496
|
647
|
427
|
-
|
|
| Total Current Liabilities |
118
|
163
|
88
|
-
|
|
| Long Term Debt |
379
|
484
|
338
|
-
|
|
| Shareholder equity |
1,723
|
2,934
|
3,180
|
-
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-220
|
-221
|
-152
|
-
|
|
| Depreciation |
79
|
82
|
39
|
-
|
|
| Cash from Investing |
-87
|
-327
|
-351
|
-
|
|
| Capex |
110
|
378
|
173
|
-
|
|
| Cash from Financing |
490
|
627
|
280
|
-
|
|
| Stock Issued |
587
|
261
|
-40
|
-
|
|
| Debt (LT) Issued |
-91
|
380
|
359
|
-
|
|
| Free Cash Flow |
-1,873
|
-1,875
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
5.0
|
2.9
|
3.3
|
-
|
|
| Financial Leverage D/E |
0.22
|
0.16
|
0.08
|
-
|
|
| Return on Capital Avg |
-72.5%
|
-44.7%
|
-2.6%
|
-
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available